Patent · US Expired

Benzo (f) insoindol derivatives and their use as ep4 receptor ligands

US7173047B2 · kind B2 · utility

1Cited by

3References

13Claims

0Family size

Assignee

Glaxo Group Limited · GB

Inventors

Gerard Martin Paul Giblin · Carnduff, GB
Stephen Frye · Durham, US
Susan Roomans · Harlow, GB

Key dates

Filing date	Dec 20, 2001
Grant date	Feb 6, 2007
Priority date	—
Expiry date	May 18, 2023

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I)and pharmaceutically acceptable derivatives thereof bind with high affinity to the EP4 receptor and are of use in the treatment or prevention of conditions such as a pain, inflammatory, immunological, bone, neurodegenerative or renal disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.